Form 8-K - Current report:
SEC Accession No. 0000950170-25-108447
Filing Date
2025-08-14
Accepted
2025-08-14 08:06:27
Documents
13
Period of Report
2025-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vivs-20250814.htm   iXBRL 8-K 58184
2 EX-10.1 vivs-ex10_1.htm EX-10.1 38211
3 EX-99.1 vivs-ex99_1.htm EX-99.1 14104
4 GRAPHIC img62398068_0.jpg GRAPHIC 16684
  Complete submission text file 0000950170-25-108447.txt   252034

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vivs-20250814.xsd EX-101.SCH 24862
15 EXTRACTED XBRL INSTANCE DOCUMENT vivs-20250814_htm.xml XML 4701
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35996 | Film No.: 251214481
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)